A carregar...
Panitumumab in the management of patients with KRAS wild-type metastatic colorectal cancer
The past 15 years has seen a marked increase in available therapeutic options for patients with metastatic colorectal cancer resulting in improvements in median survival from 12 to 24 months. One of these new options is panitumumab, which is a fully humanized monoclonal antibody that binds to the ep...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3871277/ https://ncbi.nlm.nih.gov/pubmed/24381645 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X13498660 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|